Examples of FDA Press Announcements that cite health fraud* related violations. For all FDA Press Announcements, click here.

Date	Press Announcement
11/27/2018	Statement by FDA Commissioner Scott Gottlieb, M.D., on risk of heavy metals, including nickel and lead, found in some kratom products
11/27/2018	FDA warns consumers to avoid Rhino male enhancement products found at retailers because of undeclared and potentially dangerous drug ingredients
10/23/2018	FDA launches global operation to crack down on websites selling illegal, potentially dangerous drugs; including opioids
09/11/2018	Statement from FDA Commissioner Scott Gottlieb, M.D., on new warning letters FDA is issuing to companies marketing kratom with unproven medical claims; and the agency’s ongoing concerns about kratom
08/30/2018	District Court orders permanent injunction against companies selling sexual enhancement products containing undisclosed drugs
06/05/2018	FDA takes action against 53 websites marketing unapproved opioids as part of a comprehensive effort to target illegal online sales
06/05/2018	FDA warns companies to stop selling dangerous and illegal pure and highly concentrated caffeine products
05/22/2018	FDA warns companies selling illegal, unapproved kratom products marketed for opioid cessation, pain treatment and other medical uses
05/01/2018	FDA, FTC take action against companies misleading kids with e-liquids that resemble children’s juice boxes, candies and cookies
04/03/2018	FDA orders mandatory recall for kratom products due to risk of salmonella
03/29/2018	Federal judge approves consent decree with New York dietary supplement manufacturer Riddhi USA
03/28/2018	Federal judge approves consent decree with Florida company that sold unapproved new drugs and misbranded drugs
03/02/2018	FDA warns of fraudulent and unapproved flu products
02/21/2018	FDA oversees destruction and recall of kratom products; and reiterates its concerns on risks associated with this opioid
01/24/2018	FDA, FTC warn companies for selling illegal, unapproved opioid cessation products using deceptive claims

*The FDA defines health fraud as the deceptive promotion, advertising, distribution, or sale of a product represented as being effective to prevent, diagnose, treat, cure or lessen an illness or condition, or provide another beneficial effect on health, but that has not been scientifically proven safe and effective for such purposes.